Jenburkt Pharmaceuticals Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2011. For the third quarter, the company reported net sales/income from operations of INR 143.97 million compared to INR 145.78 million a year ago. Profit from operations before other income, interest & exceptional items was INR 15.42 million compared to INR 24.28 million a year ago. Profit before tax was INR 17.17 million compared to INR 24.04 million a year ago. Net profit was INR 11.42 million or INR 2.46 per basic and diluted share compared to INR 17.04 million or INR 3.67 per basic and diluted share for the same period a year ago. For the nine months, the company reported net sales/income from operations of INR 440.62 million compared to INR 429.66 million a year ago. Profit from operations before other income, interest & exceptional items was INR 61.20 million compared to INR 74.32 million a year ago. Profit before tax was INR 60.12 million compared to INR 72.83 million a year ago. Net profit was INR 42.62 million or INR 9.17 per basic and diluted share compared to INR 50.83 million or INR 10.93 per basic and diluted share for the same period a year ago.